Anti-malware vendor Malwarebytes has completed the acquisition of vulnerability, exploit and security research and development firm ZeroVulnerabilityLabs.
The San Jose-based company specialises in technology that proactively shields software from known zero-day exploits, web-based vulnerability exploits and other corporate-targeted attacks.
It has developed multiple products, including browser and corporate editions of its flagship ExploitShield product.
Both editions include all the protections needed to prevent drive-by downloads from commercial exploit kits, Malwarebytes claims.
However, the corporate edition also has additional protection against file format targeted attacks, media format targeted attacks and advanced stealth targeted attacks.
Malwarebytes says the acquisition complements and expands its suite of anti-malware offerings, which includes Malwarebytes Anti-Malware and Malwarebytes Pro.
Marcin Kleczynski, CEO of Malwarebytes, said: "I am very pleased to announce the acquisition of ZeroVulnerabilityLabs and to welcome its employees to the Malwarebytes team.
"We are always looking to improve upon our existing offerings, and have done so with the addition of ZeroVulnerabilityLabs' technology. The proactive nature of this technology makes it a great addition ... to the existing Malwarebytes software suite."
Pedro Bustamante, co-founder and CEO of ZeroVulnerabilityLabs, added: "We are excited to be joining the Malwarebytes team and to work to advance the latest anti-exploit R&D efforts, which we started at ZeroVulnerabilityLabs.
"It is a great fit between two companies who are fighting malware in innovative and effective ways in order to protect both users and companies from the most dangerous and complex types of attacks."
ZeroVulnerabilityLabs' ExploitShield will become integrated into Malwarebytes' offerings as Malwarebytes Anti-Exploit in due course.
